Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab + Gemcitabine-Platinum in HER2+ Advanced Bladder Cancer
NCT01828736Phase 2Completed
- Sponsor
- ARTIC
- Start
- Feb 2004
- Primary completion
- Feb 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of trastuzumab in bladder cancer, sponsored by ARTIC. Started Feb 2004; status: completed.
02
Drugs
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01828736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01828736.